Calif. Judge Won't Halt Sale Of Prenatal Blood Test In IP Row

Law360, New York (July 6, 2012, 6:44 PM EDT) -- A federal judge on Thursday allowed Ariosa Diagnostics Inc. to continue selling its noninvasive prenatal Harmony test, dismissing competitor Sequenom Inc.’s motion for a preliminary injunction claiming the product infringes on its patent for a competing test.

Ariosa began marketing the test in March, after suing Sequenom in federal court in California in December for declaratory relief stating it did not infringe on its rival’s patent. Sequenon, which markets the MaterniT21 prenatal test, then moved for a preliminary injunction, seeking to prevent Ariosa from making and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.